Brief: ADC Therapeutics Says Co & Certain Of Its Subsidiaries Entered Into First Amendment To Loan Agreement & Guaranty, Dated Aug 15, 2022
19/01/2024 21:57
Jan 19 (Reuters) - ADC Therapeutics SA ADCT.N :
* ADC THERAPEUTICS SA: ON JAN 16, 2024 CO & CERTAIN OF ITS
SUBSIDIARIES ENTERED INTO FIRST AMENDMENT TO LOAN AGREEMENT &
GUARANTY, DATED AUG 15, 2022
* ADC THERAPEUTICS:AMENDMENT PROVIDES OUT-LICENSING
ARRANGEMENTS
FOR PRECLINICAL COMPOUNDS,CERTAIN TECHNOLOGIES THAT PROVIDE CASH
PROCEEDS ABOVE $75MLN
* ADC THERAPEUTICS: ON JAN 16, LENDERS TO CREDIT DEAL WAIVED
POTENTIAL NON-FINANCIAL EVENTS OF DEFAULT THAT WERE ALLEGED TO
HAVE OCCURRED THEREUNDER
Further company coverage: ADCT.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adc Therapeutics
See all newsBrief: Adc Therapeutics Announces Comprehensive Strategic Financial Restructuring Marking Key Capital Structure Improvements
ADC Therapeutics SA reports results for the quarter ended June 30 - Earnings Summary
ADC Therapeutics Q2 loss narrows; cuts 17% workforce
ADC Therapeutics SA expected to post a loss of 21 cents a share - Earnings Preview
ADC Therapeutics SA expected to post a loss of 21 cents a share - Earnings Preview